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Abstract 
Purpose: To develop and validate a new multimedia instrument to measure health-related quality of life (HRQOL) in 
Portuguese-speaking patients with cancer.
Methods: A mixed-methods study conducted in a large Brazilian Cancer Hospital. The instrument was developed 
along the following sequential phases: identification of HRQOL issues through qualitative content analysis of indi-
vidual interviews, evaluation of the most important items according to the patients, review of the literature, evalu-
ation by an expert committee, and pretesting. In sequence, an exploratory factor analysis was conducted (pilot 
testing, n = 149) to reduce the number of items and to define domains and scores. The psychometric properties of 
the IQualiV-OG-21 were measured in a large multicentre Brazilian study (n = 323). A software containing multimedia 
resources were developed to facilitate self-administration of IQualiV-OG-21; its feasibility and patients’ preferences 
(“paper and pencil” vs. software) were further tested (n = 54).
Results: An exploratory factor analysis reduced the 30-item instrument to 21 items. The IQualiV-OG-21 was divided 
into 6 domains: emotional, physical, existential, interpersonal relationships, functional and financial. The multicen-
tre study confirmed that it was valid and reliable. The electronic multimedia instrument was easy to complete and 
acceptable to patients. Regarding preferences, 61.1 % of them preferred the electronic format in comparison with the 
paper and pencil format.
Conclusions: The IQualiV-OG-21 is a new valid and reliable multimedia HRQOL instrument that is well-understood, 
even by patients with low literacy skills, and can be answered quickly. It is a useful new tool that can be translated and 
tested in other cultures and languages.
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Background
The main advantage of measuring health-related quality of 
life (HRQOL) in oncology practice is the observation of the 
clinical benefit from the patient’s perspective. Most avail-
able patient-reported outcome (PRO) instruments were 
originally developed to be self-administered by individuals 
from developed countries, usually characterized by having 
higher levels of education than Brazilians. Of note, 75  % 
of Brazilians have difficulty reading and interpreting writ-
ten texts (Ribeiro et al. 2002) and almost 80 % of Brazilian 
patients preferred that interviewers administer HRQOL 
assessment instruments (Brabo et  al. 2006). While inter-
viewer-administration is useful for respondents with read-
ing difficulties, disadvantages include the costs required to 
hire, train and supervise interviewers, and the potential for 
interviewer bias (Selltiz et al. 1976). Other sources of bias 
include social desirability (the tendency to give a favorable 
picture of oneself ) and acquiescent response sets (the ten-
dency to agree/disagree with statements regardless of their 
content) (Edwards 1957; Crowne and Marlowe 1964).
A topic of interest is the content addressed by currently 
available PROs in oncology. Both most widely-used 
cancer-specific HRQOL instruments, i.e., the European 
Organization for the Research and Treatment of Cancer 
Quality of Life Questionnaire Core 30 (EORTC QLQ-
C30) and the Functional Assessment of Cancer Therapy-
General (FACT-G), do not address existential issues. 
Specific modules for the evaluation of spirituality needs 
to be further supplemented, which increases the number 
of items and hence the time taken to complete the assess-
ment tools. Spirituality, religiosity and personal beliefs 
seems to be of utmost importance for the coping strate-
gies against cancer and its complications in Brazil, where 
only 8  % of individuals are not religious (IBGE 2012). 
Thus, we believe that a brief multidimensional cancer-
specific PRO instrument that contains items addressing 
existential issues should be further developed.
Our hypothesis was that our PRO instrument should 
have been developed from the beginning focusing on 
the low educated patients to be used later by multimedia 
programs, and not a translated PRO instrument devel-
oped in other cultures and contexts. Several PROs have 
been developed for computer-based assessment. How-
ever, most of them were designed for use in a “paper and 
pencil” form and then adapted to the electronic format. 
The inclusion of multimedia resources (audio and/or 
visual aids) is a novel concept that can be especially use-
ful for patients with low literacy skills. A new multime-
dia program—the “Talking Touchscreen”—was found to 
be acceptable, practical and user-friendly, thus providing 
opportunities to measure HRQOL in English- and Span-
ish-speaking patients with a range of literacy skills (Hahn 
et al. 2004; Yost et al. 2010).
The aim of this study was to develop and validate a 
new multimedia PRO instrument to measure HRQOL in 




The study complied with the ethical standards of the 
Declaration of Helsinki and Brazilian National Health 
Council resolution no. 466/2012. The study was approved 
by the Research Ethics Committee of the Barretos Can-
cer Hospital (Barretos-SP, Brazil, no 100.449). The Eth-
ics Committee at the other participating centers also 
approved the study. Informed consent was obtained from 
all individual participants included in the study.
Phase I: Qualitative study—identification of the 
health‑related quality of life content
Selection of participants
The inclusion criteria were as follows: histological diag-
nosis of cancer (regardless of the cancer type and current 
treatment), age 18 years or older, have knowledge about 
the diagnosis of cancer, and ability to communicate in the 
Brazilian Portuguese language. Patients with any uncon-
trolled psychiatric disease or significant cognitive dys-
function were not eligible to participate. In the Phase I, 
at least 5 patients should be of low education status (less 
than 8  years of formal education); two of them should 
be illiterate or with less than 2 years of education. Each 
subgroup (cancer survivors; systemic adjuvant or neo-
adjuvant treatment; systemic palliative treatment; pallia-
tive care only) should be composed of similar number of 
participants, in order to represent all stages of the cancer 
care continuum.
Data collection
A convenience sample of patients with cancer was 
recruited from the Outpatient and Inpatient Units of the 
Clinical Oncology and Palliative Care Departments. They 
were interviewed individually by two researchers with 
previous experience in conducting qualitative research 
(CEP and BSRP).
Patients answered the following eight open-ended 
questions: (1) How does your medical condition or your 
treatment interfere with your physical health?; (2) How 
does your medical condition or your treatment interfere 
with your emotional health?; (3) How does your medi-
cal condition or your treatment interfere with your social 
activities (going out, having fun, connecting with family 
and/or friends)?; (4) How does your medical condition 
or your treatment interfere with your finances?; (5) How 
does your medical condition or your treatment inter-
fere with your religious/spiritual life?; (6) If you compare 
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yourself today with when you were not sick, what do 
you think has changed in your life?; (7) What did you 
do before getting sick that you do not do today?; and (8) 
What worries you the most currently?
Data analyses
The interviews were recorded and transcribed verbatim 
for subsequent content analysis according to Bardin’s 
methodology (1994). The first step was the pre-analysis, 
which consisted of direct and intense contact with the 
material and organization of the data to meet the evalu-
ation standards, including exhaustiveness, representa-
tiveness, homogeneity and relevance. The next step was 
to organize the topics according to their relevance and/
or repetition (codification and categorization of the 
data). The transcripts were independently coded into cat-
egories by two researchers; disagreements in coding were 
resolved during a consensus meeting. Finally, the raw data 
were divided into percentages and interpreted (treatment 
and interpretation of the obtained results). The criterion 
of data saturation was used to define the sample size for 
this phase (Miles and Huberman 1994).
Phase II: Identification of the most relevant items
Instrument development strategy
Considering the content identified in the qualitative analysis, 
the authors created a pool of items for each category identi-
fied in the qualitative analysis. The items were grouped into 
a questionnaire using 5-point Likert-type responses (“not at 
all important”, “slightly important”, “moderately important”, 
“very important” and “extremely important”).
Selection of participants
The inclusion criteria were as follows: histological diag-
nosis of cancer (regardless of the cancer type and current 
treatment), age 18 years or older, have knowledge about 
the diagnosis of cancer, and ability to communicate in the 
Brazilian Portuguese language. Patients with any uncon-
trolled psychiatric disease or significant cognitive dys-
function were not eligible to participate.
Data collection
The instrument was administered to a sample of patients 
on “paper and pencil” format in private rooms at the out-
patient units. Trained research coordinators from the 
Center for Research Support (Barretos Cancer Hospital) 
conducted all the interviews.
Data analyses
The items with the highest percentage of “extremely 
important” responses and those with the highest per-
centage of classification as among the 10 most important 
items were identified; these items were retained for the 
next study phase.
Phase III: Development of the instrument, pretesting 
and pilot testing
Instrument development strategy
The new instrument was developed with standardized 
questions that always followed the same format (start-
ing with “how often…”) and used the same response scale 
(“never” to “very often”). A consensus indicated that the 
assessment period would be the 2  weeks immediately 
preceding the administration of the instrument, which 
was considered appropriate for patients with different 
stages of cancer. Considering that the ultimate goal was 
the development of software with audiovisual resources, 
an answer scale with figures was developed to facilitate 
the responses of patients with lower educational levels. 
The figures were built as squares that were filled with 
increasing amounts of small black spots and ranged from 
empty (never) to almost completely filled (very often) 
(see Additional file 1).
The instrument was evaluated by an expert commit-
tee that consisted of 8 members (3 clinical oncologists, 1 
biologist, 3 nurses and 1 surgical oncologist), 3 of whom 
had experience developing and validating healthcare 
assessment instruments. All members independently 
critiqued the instrument using a form designed for the 
study. Two authors grouped all the reviews into a single, 
blinded version of the critiques that was subsequently 
evaluated by all committee members.
Selection of participants
The inclusion criteria were as follows: histological diag-
nosis of cancer (regardless of the cancer type and cur-
rent treatment), age 18  years or older, have knowledge 
about the diagnosis of cancer, and ability to communicate 
in the Brazilian Portuguese language. Patients with any 
uncontrolled psychiatric disease or significant cognitive 
dysfunction were not eligible to participate. Pretesting 
was performed with 15 cancer patients who had differ-
ent educational levels; at least 10 with low education level 
(less than 8 years of education) and among them, at least 
5 with less than 2 years of education.
Data collection
In the pretesting, cognitive debriefing interviews were 
conducted by experienced interviewers using a semi-
structured interview guide.
A subsequent pilot testing was performed with 149 
patients with cancer recruited at the Barretos Can-
cer Hospital. All participants responded to the 30-item 
instrument in “paper and pencil” format.
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Data analysis
Pretesting—Participants were requested to explain what 
they understood about each item, thus creating an assess-
ment of the “participant’s comprehension of the item”. In 
addition, the patients noted whether the item was con-
fusing or embarrassing and whether they suggested any 
change to the instrument. A think-aloud method with 
cognitive debriefing was used.
Pilot testing (reduction of items)—The instrument 
containing 30 items was initially submitted to an explor-
atory factor analysis. It was performed using principal 
component analysis  and varimax rotation. An Eigen-
value >1 was defined to extract the factors in the explor-
atory phase. The adequacy of the data for the factor 
analysis was identified using the Kaiser–Meyer–Olkin 
(KMO) test and Bartlett’s test of sphericity. During the 
initial exploratory factor analysis, the items that had 
low factor loadings (<0.4) in all domains were excluded. 
Other exclusion criteria were a percentage of unan-
swered items >4 % and a correlation coefficient between 
items of the same domain >0.8. After the initial exclu-
sion of items, a new exploratory factor analysis was per-
formed to define the domains. Statistical analyses were 
performed using SPSS software (version 20.0, Chicago, 
IL, USA).
Phase IV: Evaluation of the psychometric properties of the 
IQualiV‑OG‑21—multicentre Brazilian study
Selection of participants
The inclusion criteria were as follows: histological diag-
nosis of cancer (regardless of the cancer type and cur-
rent treatment), age 18  years or older, have knowledge 
about the diagnosis of cancer, and ability to commu-
nicate in the Brazilian Portuguese language. Patients 
with any uncontrolled psychiatric disease or significant 
cognitive dysfunction were not eligible to participate. 
Patients were recruited from four different Hospitals: 
Barretos Cancer Hospital (Barretos-SP, Brazil), Botu-
catu’s Medical School (Botucatu-SP Brazil), Oncology 
Institute of Ribeirão Preto (Ribeirão Preto-SP, Brazil) 
and Mater Dei Hospital (Belo Horizonte-MG, Brazil). 
The first two centers belong to the Brazilian public 
health system, and the other two serve insured or pri-
vate patients.
Data collection
All participants responded the IQualiV-OG-21 in “paper 
and pencil” format and then completed both the Func-
tional Assessment of Cancer Therapy-General (FACT-G) 
and the Functional Assessment of Chronic Illness Ther-
apy-Spiritual Well-Being scale (FACIT-sp-12). To ensure 
high data quality, study procedures were standardized 
through in-person or video conference meetings.
Validation instruments
The Functional Assessment of Cancer Therapy-General 
(FACT-G) contains 27 items on a 4-point Likert-type 
scale assessing four domains of “well-being” (physical, 
social/family, emotional and functional); higher scores 
indicate better HRQOL (Cella et  al. 1993). It has been 
translated to and validated for Portuguese (Ishikawa et al. 
2010).
The Functional Assessment of Chronic Illness Ther-
apy-Spiritual Well-Being scale (FACIT-sp-12) consists 
of 12 items and two sub-domains of spiritual well-being 
(peace/meaning and faith). Higher scores indicate higher 
levels of spiritual well-being (Peterman et al. 2002). It has 
been previously validated in Brazil (Lucchetti et al. 2013).
Data analyses
The factor structure for the IQualiV-OG-21, which was 
defined in Phase III, was tested in Phase IV (multicenter 
study); maximum likelihood estimation was used for 
the confirmatory factor analysis. To test goodness of fit 
we used the comparative fit index (CFI) and the Tucker-
Lewis Index (TLI). For both, values ≥0.95 indicate a good 
fit, and values >0.90 an acceptable fit (Hu and Bentler 
1999). Additionally, Root Mean Square Error of Approxi-
mation (RMSEA) values below 0.08 are considered to 
reflect acceptable fit to the model and values smaller 
than 0.05 as good fit (Schermelleh-Engel et al. 2003). As 
a requirement, all standardized factor loadings need to be 
greater than 0.4 and statistically significant.
The internal consistency reliability of each subscale was 
assessed using Cronbach’s coefficient alpha; values above 
0.70 were considered adequate (Terwee et al. 2007).
Sixty four patients from the phase IV cohort were 
retested after 7–14 days to measure the test–retest reli-
ability. It was assessed using the intraclass correlation 
coefficient (ICC); values above 0.70 were considered ade-
quate (Terwee et al. 2007).
Known-group validity was assessed by comparing the 
mean IQualiV-OG-21 subscales scores between groups 
of patients with Eastern Cooperative Oncology Group 
Performance Status (ECOG-PS) values of 0–1 versus 
2–4. A t test was used for these comparisons. Addition-
ally, Cohen’s effect size (ES) was calculated to indicate the 
magnitude of the differences between groups, defined as 
the difference in scores between the ECOG-PS 0–1 and 
2–4 groups divided by the combined standard deviation 
of both groups. Effect size values of <0.2, 0.2–0.49, 0.5–
0.79 and ≥0.8 were classified as negligible, small, moder-
ate and large differences, respectively (Fayers and Machin 
2007). We hypothesized that the physical, functional and 
overall domains would be the most discriminative. For 
convergent validity, the IQualiV-OG-21 scores were com-
pared with the corresponding scores on the FACT-G and 
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FACIT-sp-12 instruments. Correlation coefficients ≥0.4 
were considered adequate (Fayers and Machin 2007).
Statistical analyses were performed using SPSS soft-
ware (version 20.0, Chicago, IL, USA) and confirmatory 
factor analysis was accomplished with SPSS Amos ver-
sion. 20.0 (version 20.0, Chicago, IL, USA). A nominal 
significance level (p < 0.05) was used to interpret results.
Phase V: Development of the software containing the 
IQualiV‑OG‑21
Software development
In brief, the software was developed in Java program-
ming language and contained audio–visual resources 
(recorded reading of the instructions, questions and 
response choices, and interactive icons). The software 
was designed so that even illiterate respondents could 
answer the instrument without the need for application 
by an interviewer. One item at a time is presented on the 
computer touchscreen. Small picture icons appear below 
each text element allowing patients to replay the sound 
if necessary, to skip to the next item without answering, 
and allowing return to previous items to correct errors or 
change answers.
Phase VI: Comparison between “paper and pencil” 
and software IQualiV‑OG‑21 formats
Selection of participants
The inclusion criteria were as follows: histological diag-
nosis of cancer (regardless of the cancer type and current 
treatment), age 18 years or older, have knowledge about 
the diagnosis of cancer, and ability to communicate in the 
Brazilian Portuguese language. Patients with any uncon-
trolled psychiatric disease or significant cognitive dys-
function were not eligible to participate.
Data collection
A new sample of fifty four cancer patients answered the 
IQualiV-OG-21 in both “paper and pencil” and software 
formats. The order of administration was randomized. 
Between the administrations of the instruments, patients 
were evaluated regarding their functional literacy lev-
els using the Multidimensional Screener of Functional 
Health Literacy (MSFHL). The MSFHL is a simple 
screening tool which provides an accurate prediction of a 
patient’s functional literacy status. It consists of six items 
that provide a score ranging from 0 to 10; scores are cat-
egorized as inadequate (0–3), marginal (4–5) and ade-
quate (6–10) functional literacy levels (Apolinario et  al. 
2014). In addition, patients reported their preferences 
about the best format (“paper and pencil” vs. indiffer-
ent vs. software). Afterwards, the patients were classified 
by the interviewer regarding their ability to answer the 
instrument in a self-administered format.
Data analyses
Descriptive statistics were used to describe differences 
between patient’s preferences and abilities to answer the 
instruments.
Results
Phase I: Qualitative study
Data saturation was identified after the initial evalua-
tion of 20 patients. Table  1 shows the characteristics of 
the patients included in this phase. The interviews lasted 
approximately 20  min. After the transcriptions were 
coded, 5 categories were identified (“physical”, “emo-
tional”, “financial”, “social” and “existential”). The cate-
gory “physical” was subdivided into 7 subcategories; the 
category “emotional” into 4 subcategories; the category 
“financial” into 2 subcategories; the category “social” 
into 5 subcategories; and the category “existential” into 
6 subcategories. Based on these results, the investigators 
developed a questionnaire with 43 items to use in the 
next study phase.
Phase II: Identification of the most relevant items
Sixty patients answered a questionnaire contain-
ing 43 items. The items with the highest percentage of 
“extremely important” responses and the percentage of 
times they were classified among the 10 most important 
were identified. From this analysis, the selected items 
were divided into physical symptoms (8 items), emo-
tional problems (4 items), functionality (1 item), social 
problems (2 items) and existential problems (2 items), 
for a total of 17 items. After reviewing the literature, 
the authors of the instrument decided to include 8 more 
items that aimed to assess the following: functional-
ity (1 item), anxiety (1 item), interpersonal relationships 
(2 items), fun and leisure (1 item) inner peace (1 item), 
irritability (1 item) and financial aspects (1 item). Table 1 
shows the characteristics of the patients included in this 
phase.
Phase III: Construction of the initial version of the 
instrument, pretesting and pilot testing
The initial version of the instrument with 25 items was 
evaluated for content validity by an expert commit-
tee. Two authors of the study analyzed the committee 
members’ critiques and decided to include 5 more items 
to assess the following constructs: overall assessment 
of HRQOL (1 item), sexuality (1 item), meaning of life 
(1 item), prayer (1 item) and the importance of faith in 
fighting the disease (1 item). Additional file 2 details the 
construction of the initial version of IQualiV-OG with 30 
items. The new version with 30 items was again evalu-
ated by all members of the expert committee, who con-
sidered the content adequate for an instrument that aims 
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Table 1 Sociodemographic and clinical characteristics of the patients included in the study
Characteristic Phase I Phase II Phase III Phase IV Phase VI
(n = 20) (n = 60) (n = 149) (n = 323) (n = 54)
n % n % n % n % n %
Gender
 Male 8 40.0 27 45.0 49 32.9 151 46.7 36 60.0
 Female 12 60.0 33 55.0 100 67.1 172 53.3 24 40.0
Age (years)
 <40 1 5.0 12 20.0 39 26.2 45 13.9 10 16.7
 40–65 16 80.0 35 58.3 91 61.1 197 61.0 41 68.3
 ≥65 3 15.0 13 21.7 19 12.8 81 25.1 9 15.0
Educational level (years of formal schooling)
 Illiterate 0 0 0 0 4 2.7 16 5.0 4 6.7
 <8 5 25.0 23 38.3 56 37.6 145 44.9 27 45.0
 8–11 6 30.0 16 26.7 26 17.4 84 26.0 24 44.0
 >11 9 45.0 21 35.0 63 42.3 78 24.1 5 8.3
Family income (expressed as multiples of the minimum wage)
 ≤1 3 15.0 14 25.0 29 19.7 52 17.9 23 38.3
 1–2 8 40.0 11 19.6 51 34.7 63 21.7 18 30.0
 2.1–3 4 20.0 12 21.4 26 17.7 49 16.9 10 16.7
 >3 5 25.0 19 33.9 41 27.9 126 43.4 7 12.0
 Missing 0 4 2 33 2
Brazilian region of origin
 Southeast 14 70.0 42 70.0 106 71.1 257 79.6 43 71.7
 Southern 0 0 1 1.7 1 0.7 1 0.3 0 0.0
 Northern 1 5.0 4 6.7 7 4.7 22 6.8 7 11.7
 Midwest 5 25.0 13 21.7 34 22.8 40 12.4 8 13.3
 Northeast 0 0 0 0 1 0.7 3 0.9 2 3.3
Type of primary tumor
 Breast 5 25.0 12 20.0 53 35.6 73 22.6 5 8.3
 Colorectal 4 20.0 15 25.0 25 16.8 38 11.8 3 5.0
 Prostate 2 10.0 7 11.7 10 6.7 33 10.2 2 3.3
 Cervix 1 5.0 3 5.0 16 10.7 19 5.9 0 0
 Gastric 1 5.0 1 1.7 8 5.4 9 2.8 0 0
 Lung 0 0 4 6.7 3 2.0 22 6.8 0 0
 Head and Neck 0 0 4 6.7 2 1.3 33 10.2 40 66.7
 Esophageal 1 5.0 1 1.7 4 2.7 7 2.2 0 0
 Endometrial 0 0 0 0 2 1.3 1 0.3 0 0
 Others 6 30.0 13 21.7 26 17.4 88 27.2 10 16.7
Distant metastasis
 Yes 11 55.0 31 52.0 61 41 158 48.9 15 25.0
 No 9 45.0 29 48.0 88 59 165 51.1 45 75.0
Type of current treatment
 Follow-up (NED) 0 0 11 18.3 16 10.7 45 13.9 3 5.0
 Curative/Adj/Neoadj systemic therapy 4 20.0 18 30.0 72 48.3 120 37.2 45 75.0
 Palliative systemic therapy 10 50.0 21 35.0 56 37.6 132 40.9 10 16.7
 Palliative care only 6 30.0 10 16.7 5 3.5 26 8.0 2 3.3
Place of interview
 Ambulatory 9 45.0 56 93.0 117 78.5 288 89.2 59 98.3
 Hospital 11 55.0 4 7.0 32 21.5 35 10.8 1 1.7
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to measure the HRQOL of patients with general cancer. 
Some adjustments were made to the instrument’s state-
ments, the presentation order of a few items and the 
language of 3 items that were considered confusing by 
patients.
A total of 180 patients were invited to participate in the 
pilot test; of these, 152 agreed to participate. Three cases 
were subsequently excluded from the statistical analyses 
because of screening failure (there were cases of in  situ 
carcinomas). Table  1 shows the sociodemographic and 
clinical characteristics of the study participants.
The KMO and Bartlett’s test values were adequate 
(KMO  =  0.784, p  <  0.001), indicating that the sample 
could be subjected to factor analysis. The exploratory 
factor analysis of the instrument with 30 items identi-
fied 9 factors that explained 68.5 % of the total variance. 
Nine items were excluded because they were grouped 
into factors other than the one they had been originally 
devised for. Table 2 shows the factor loadings for the 21 
items that were retained. Item 1, which assesses the fre-
quency of pain, was grouped into the emotional factor 
and not into the physical factor; however, considering this 
item’s importance to the instrument, the authors decided 
to keep it in the analysis of the domain for which it was 
devised (the physical domain). None of the items were 
excluded based on the percentage of missing responses 
or inter-item correlations within the same factor >0.8. 
After 9 items were excluded, the instrument was named 
the “Instrumento para avaliação da Qualidade de Vida 
em Oncologia Geral com 21 itens” (IQualiV-OG-21) and 
was composed of 21 items divided into 6 domains: emo-
tional (6 items), physical (5 items), existential (3 items), 
interpersonal relationships (2 items), functional (3 items) 
and financial (2 items). Physical domain included items 
assessing physical symptoms (pain, fatigue, nausea, etc.); 
otherwise, functional domain included items measur-
ing physical functioning (ability to work, take care of 
itself, and need to rest). The original instrument in Por-
tuguese and a preliminary English translation are avail-
able in Additional file  1. The scores for each domain 
were developed using the mean of the answered items 
on a normalized scale ranging from 0 to 100, with higher 
scores representing worse HRQOL. We considered 
HRQOL as a multi-dimensional concept that includes dif-
ferent domains related each other; additionally, a compos-
ite score would represent the global HRQOL. Thus, the 
overall score, which is the mean of all domains, was also 
created.
Phase IV: Evaluation of the psychometric properties 
(multicentre study)
From the 379 patients invited to participate in the study, 
323 agreed to participate; Barretos Cancer Hospital 
(n = 181), Botucatu’s Medical School (n = 49), Oncology 
Institute of Ribeirão Preto (n = 50) and Mater Dei Hos-
pital (n = 43). Table 1 details the patient characteristics.
The IQualiV-OG-21 was completed in a mean (SD) of 
6.0 (3.3) minutes, ranging from 1.2 to 23  min. None of 
the items had an unanswered percentage >4  %, values 
ranged from 0 to 0.9 %.
Regarding the confirmatory factor analysis, fit indi-
ces were considered good (CFI  =  0.950, TLI  =  0.933, 
RMSEA  =  0.051) and all factor loadings were greater 
than 0.40 and statistically significant.
The domains with the lowest (most favorable) mean 
scores were the personal relationship (mean = 13.4) and 
existential domains (mean = 15.2), and the domains with 
the highest (least favorable) scores were the emotional 
(mean  =  41.7) and financial (mean  =  39.6) domains 
(Table 3). Internal consistency reliability was considered 
adequate, with Cronbach’s alpha values ranging from 0.75 
(for the personal relationship domain) to 0.90 (for the 
overall score; Table 3).
Test–retest reliability was assessed in 64 partici-
pants using the ICC and was considered adequate in all 
domains, ranging from 0.79 (physical domain) to 0.96 
(existential domain; Table 3).
Convergent validity was confirmed by the Pearson cor-
relation between the IQualiV-OG-21 domains and the 
corresponding domains of the FACT-G and FACIT-sp-12 
NED no evidence of disease, Adj Adjuvant, Neoadj Neoadjuvant, ECOG Eastern Cooperative Oncology Group
Table 1 continued
Characteristic Phase I Phase II Phase III Phase IV Phase VI
(n = 20) (n = 60) (n = 149) (n = 323) (n = 54)
n % n % n % n % n %
ECOG performance status
 0–1 8 40.0 NA – 109 73.2 220 68.8 54 90.0
 2–4 12 60.0 NA – 39 26.2 100 31.3 6 10.0
 Missing 3
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instruments. All expected correlations had coefficients 
greater than 0.4, with only two exceptions: personal rela-
tionship and FACT-G social (r = −0.242), and existential 
and FACIT-sp 12 faith (r = −0.315) (Table 4).
Known-groups validity was assessed by comparing the 
IQualiV-OG-21 scores of patients who presented better 
(ECOG-PS of 0-1) and worse (ECOG-PS of 2-4) func-
tional performances. As expected, the magnitude of the 
difference was greatest in the following domains: physical 
(ES  =  0.95), functional (ES  =  1.16) and overall score 
(ES = 0.90; Table 5).
Phase VI: Comparison between “paper and pencil” 
and software IQualiV‑OG‑21 formats
Among the 54 participants in the method compari-
son sub-study, there were 29 (53.7  %), 9 (16.7  %) and 
16 (29.6  %) patients classified as inadequate, marginal 
and adequate functional literacy levels, respectively, 
Table 2 Factor analysis of the IQualiV-OG-21 (n = 149)
a The brief item descriptors approximate the questions asked in each item
Factor loadings are italicized when grouped in a same domain
Emotion. emotional, Existen. existential, Relation. interpersonal relationships, Function. functional
Item Descriptorsa Factors
Emotion Physical Existen Relation Function Financial
6 Insomnia 0.482 0.064 0.129 0.280 0.126 0.281
17 Depressed 0.652 0.133 0.247 0.252 0.069 0.239
18 Anxious 0.736 −0.047 0.147 0.138 −0.064 0.251
19 Easily irritated 0.702 0.228 0.172 0.257 −0.095 0.023
21 Fear of worsening health 0.588 0.012 0.335 −0.207 0.160 0.145
22 Worry about the family’s future 0.572 0.032 0.055 −0.059 0.191 0.460
1 Pain 0.588 0.189 −0.165 0.358 0.348 −0.050
2 Weak or without energy 0.399 0.582 −0.045 0.197 0.219 −0.204
4 Lack of appetite 0.076 0.742 0.084 −0.089 0.118 0.347
5 Limited ability to taste foods −0.061 0.755 0.095 0.153 0.161 0.081
7 Nauseated 0.142 0.777 0.117 0.062 0.009 0.121
24 Hopeless 0.203 0.111 0.784 0.073 0.169 0.008
25 Lost faith in God 0.144 0.068 0.786 0.215 −0.004 0.153
29 Life did not make sense 0.109 0.088 0.759 0.077 0.051 −0.009
15 Relationship problems 0.225 0.112 0.132 0.762 0.015 0.177
16 People distanced themselves 0.151 0.059 0.205 0.795 0.107 0.064
9 Needing help to get dressed, shower or eat 0.067 −0.001 0.020 −0.034 0.821 −0.017
10 Unable to work 0.107 0.260 0.120 0.313 0.689 0.318
11 Needing to lie down or sit to rest 0.058 0.407 0.243 0.043 0.648 0.021
12 Worried about finances 0.263 0.180 0.084 0.051 0.113 0.773
13 Not enough money to meet needs 0.259 0.180 0.017 0.298 −0.049 0.744
Table 3 Mean values, internal consistency and test–retest analysis of IQualiV–OG-21
SD standard deviation, ICC intraclass correlation coefficient
a n = 64
IQualiV‑OG‑21 domains Number of items Mean (SD) Cronbach’s α (95 % CI) ICC (95 % CI)a
Emotional 6 41.7 (24.9) 0.85 (0.82–0.87) 0.88 (0.80–0.93)
Physical 5 33.0 (23.8) 0.79 (0.75–0.82) 0.79 (0.66–0.88)
Financial 2 39.6 (32.4) 0.81 (0.77–0.85) 0.83 (0.72–0.90)
Existential 3 15.2 (22.2) 0.81 (0.77–0.84) 0.96 (0.94–0.98)
Functional 3 28.9 (25.9) 0.77 (0.72–0.81) 0.86 (0.77–0.92)
Personal relationships 2 13.4 (20.7) 0.75 (0.69–0.80) 0.94 (0.90–0.97)
Total score 21 28.7 (17.7) 0.90 (0.89–0.92) 0.95 (0.92–0.97)
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according to the Multidimensional Screener of Func-
tional Health Literacy. Twelve (n = 12, 22.2 %; inadequate 
functional literacy = 10, marginal functional literacy = 2) 
participants required the application of the IQualiV-
OG-21 in “paper and pencil” form by the interviewer. 
Interestingly, fifteen (n  =  15, 27.8  %; inadequate func-
tional literacy = 9, marginal functional literacy = 3, ade-
quate functional literacy =  3) participants initially tried 
to self-administer the instrument in “paper and pencil” 
form, nevertheless they were unable to complete it; the 
application by the interviewer were also required. All 
participants were able to self-administer the electronic 
IQualiV-OG-21 and only 4 (7.4 %) patients required sig-
nificant help by the interviewer. Regarding their prefer-
ences about the best format, 6 (11.1 %) patients preferred 
the “paper and pencil” format, 15 (27.8 %) reported both 




In this study, we present the first cancer-specific HRQOL 
instrument developed as a multimedia electronic tool for 
Portuguese-speaking patients. The IQualiV-OG-21 dem-
onstrated good psychometric properties, and its electronic 
form was practical and well accepted by patients with can-
cer. By overcoming barriers to self-administration, this 
new instrument provides greater opportunities to meas-
ure HRQOL in patients with a range of literacy skills. 
Our findings are in accordance with previous studies con-
ducted in patients with low literacy skills from Spanish- 
and Chinese-speaking populations (Hahn et al. 2003, 2004, 
2007; Hahn and Cella 2003; Thumboo et al. 2006).
Limitations and strengths of the study
The study has some limitations. We enrolled only 
ambulatory cancer patients who were well enough to 
participate. Results may not be generalizable to patients 
with greater disease severity and poorer HRQOL. The 
personal relationship domain of the IQualiV-OG-21 
was weakly associated with the social domain of the 
FACT-G. This may be due to the fact that the social 
domain of the FACT-G measures a broader concept 
than our tool which is focused on relationship quality. 
Future studies should correlate the personal relation-
ship domain with other instruments that more closely 
measure similar concepts. Similarly, the lack of a stand-
ard instrument that can be used to correlate the finan-
cial domain scores of the IQualiV-OG-21 is another 
limitation of that could be addressed in future stud-
ies. It might be useful to consider other psychometric 
approaches to scoring, such as item response theory 
(Van der Linden and Hambleton 1997) or the Rasch 
model (Bond and Fox 2007). Another limitation is that 
the IQualiV was not developed and tested initially as 
software format, but in “paper and pencil” form. The 
software was developed throughout the initial phases 
Table 4 Pearson correlations between IQualiV-OG-21 and FACT-G and FACIT-sp-12 (n = 323)
* p < 0.01.  Underline indicates a pair of scales that should correlate theoretically 
IQualiV‑OG‑21 FACT‑G FACIT‑sp‑12
Physical Emotional Functional Social Total Meaning/peace Faith Spirituality total
Emotional −0.55* −0.63* −0.40* −0.07 −0.53* −0.29* −0.01 −0.24*
Physical −0.72* −0.47* −0.47* −0.17* −0.61* −0.41* −0.25* −0.38*
Financial −0.33* −0.31* −0.27* −0.09 −0.33* −0.21* −0.06 −0.17*
Existential −0.51* −0.60* −0.48* −0.18* −0.57* −0.48* −0.32* −0.46*
Functional −0.70* −0.45* −0.61* −0.21* −0.65* −0.44* −0.28* −0.41*
Personal relationships −0.22* −0.26* −0.19* −0.24* −0.29* −0.29* −0.15* −0.26*
Total score −0.71* −0.63* −0.57* −0.22* −0.69* −0.49* −0.26* −0.44*
Table 5 Known-group validation according to  the perfor-
mance status
SD standard deviation, ∆ difference between the two groups, ES effect size
a  T test






Emotional 37.6 (24.7) 50.9 (23.3) <0.001 13.22 0.53
Physical 25.9 (22.0) 48.6 (20.2) <0.001 22.71 0.95
Financial 33.7 (31.8) 51.6 (30.5) <0.001 17.87 0.55
Existential 11.6 (20.6) 23.4 (23.5) <0.001 11.87 0.53
Functional 19.6 (20.4) 49.8 (24.7) <0.001 30.27 1.16
Personal relationships 13.5 (20.8) 13.4 (20.8) 0.952 −0.14 −0.00
Total score 23.6 (16.3) 39.6 (15.6) <0.001 17.67 0.90
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of the study, therefore, unfortunately, it was considered 
ready for use only in the Phase VI. Further data are 
needed about the software in a large cohort of patients 
with cancer. Moreover, the comparison between 
IQualiV-OG-21 software and other standard similar 
questionnaires is awaited.
In terms of strengths, we can point out the original-
ity of the study, since only a handful of multimedia-con-
taining HRQOL instruments have been developed so far. 
Another strength is the external validation in a multi-
centre cohort comprising patients from different social 
and educational skills. Furthermore, the IQualiV-OG-21 
includes a specific existential domain, which seems to be 
relevant for its use when evaluating patients with can-
cer, since spirituality and religiosity are commonly used 
as coping strategies by Brazilians (Paiva et al. 2011). The 
widely-used PRO instruments EORTC QLQ-C30 and 
FACT-G do not evaluate existential aspects and thus 
require the administration of specific supplements for 
this purpose.
Implications for clinicians and researchers
Brazil is a continental country, with about 200 million 
inhabitants and 576 thousand new cases of cancer each 
year (INCA 2014; IBGE 2015). HRQOL measurement 
has practical implications for use in cancer care, such 
as improving communication, screening symptoms and 
triggering protocols, monitoring responses, facilitating 
shared decision making, etc. (Hearn and Higginson 1997; 
Higginson and Carr 2001; Greenhalgh 2009). In addi-
tion, considering the large number of Brazilian patients 
with low literacy skills, the electronic IQualiV-OG-21 is a 
useful new instrument for routine practice and research. 
Responses are automatically recorded in spreadsheets 
and there will be cost saving because of the lack of need 
of typists and trained interviewers. Currently, we are 
leading the ProQualiV program (Programa de Qualidade 
de Vida como um Indicador Vital) aiming to establish 
the measurement of HRQOL as a routine vital indicator 
in a large comprehensive cancer hospital in Brazil; elec-
tronic IQualiV-OG-21 is an ideal tool to be used in this 
program.
Unanswered questions and future research
An unanswered question is the lack of assessment of 
the IQualiV-OG-21’s responsiveness, which is consid-
ered important for its future practical use in longitudinal 
assessments of patients with cancer (Reeve et  al. 2013). 
Future evaluation of minimal clinically important differ-
ences is also needed. Although the electronic IQualiV-
OG-21 is user-friendly, acceptable, valid and reliable in 
Brazil, it should be translated and tested in other cultures 
and languages. To be useful in practice, an instrument 
needs not only to have good psychometric properties, 
but it also needs to have equivalent linguistic versions in 
several populations to be useful in international clinical 
trials.
Conclusions
We present the first electronic PRO multimedia instru-
ment for oncology developed to measure the HRQOL 
of Brazilian patients with cancer. The IQualiV-OG-21 
can be considered well-valid, and reliable. The electronic 
form is acceptable and easy to complete, even by patients 
with low literacy skills.
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